A view of selected publications from our research group, highlighting recent work in MRI-guided radiotherapy, clinical outcomes, and data-driven approaches to cancer care. These studies reflect our ongoing efforts to improve precision, personalize treatment, and advance patient outcomes in radiation oncology.
Fang B, Zahary Loreman H, Bayley C, Stewart C, George K, Al-Amoodi M, Jooya A, Quon H, Sia M, and Lee SL. Evaluation of efficacy in prostate cancer contouring for MR-guided radiotherapy using structured contouring training modules. Technical Innovations & Patient Support in Radiation Oncology. 2026;38:100390. https://doi.org/10.1016/j.tipsro.2026.100390
Zhang, J., Bayley, C., Vaska, M. & Lee, S. L. Optimizing peer review rounds in radiation oncology: a scoping review. Front. Oncol. 16, (2026). doi:10.3389/fonc.2026.1686796
Ryu, D.-G., Kim, K., Liu, H., Lee, S. S. & Lee, S. L. Clinical Features and Prognosis of Cervical Esophageal Cancer. Journal of Clinical Medicine 14, 3803 (2025). doi:10.3390/jcm14113803
Ryu, D. G., Yu, F., Liu, H., Lee, S. S. & Lee, S. L. Clinical Outcomes and Prognosis of Esophageal Squamous Cell Carcinoma Presenting with Obstruction. J Gastrointest Canc 56, 1–11 (2025). doi:10.1007/s12029-024-01159-8
Xu, Y., Chow, R., Murdy, K., Mahsin, M., Chandereng, T., Sinha, R., Lee-Ying, R., Abedin, T., Cheung, W. Y., Thanh, N. X. & Lee, S. L. Definitive Chemoradiotherapy versus Trimodality Therapy for Locally Advanced Esophageal Adenocarcinoma: A Multi-Institutional Retrospective Cohort Study. Cancers 16, 2850 (2024). doi:10.3390/cancers16162850
Wong, R., Anderson, B., Bashir, B., Bateman, J., Chalchal, H., Davies, J., Dehmoobed, A., Geller, G., Ghose, A., Gill, S., Gordon, V., Green, S., Hebbard, P., Iqbal, M., Ji, S., Karachiwala, H., Kidane, B., Kim, C., Kosyachkova, E., Krahn, M., Krishnan, T., Kristjanson, M., Lee, S., Lee-Ying, R., Lelond, S., Liu, H.-W., Meyers, D., Mulder, K., Paul, J. & Planincic, E. Report from the 25th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Gastric and Gastroesophageal Cancers, Winnipeg, Manitoba, 26–27 October 2023. Current Oncology 31, 5987–6006 (2024). doi:10.3390/curroncol31100447
Ryu, D. G., Yun, M. S., Liu, H., Lee, S. S. & Lee, S. L. Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis. Clinical and Translational Radiation Oncology 48, 100817 (2024). doi:10.1016/j.ctro.2024.100817
Lee, S. L., Yadav, P., Li, Y., Meudt, J. J., Strang, J., Hebel, D., Alfson, A., Olson, S. J., Kruser, T. R., Smilowitz, J. B., Borchert, K., Loritz, B., Gharzai, L., Karimpour, S., Bayouth, J. & Bassetti, M. F. Dataset for gastrointestinal tract segmentation on serial MRIs for abdominal tumor radiotherapy. Data in Brief 57, 111159 (2024). doi:10.1016/j.dib.2024.111159
Barrett, F., Quirk, S., Stenhouse, K. J., Long, K., Roumeliotis, M., Lee, S. L., Souza, R. & McGeachy, P. Development of a Machine Learning Tool to Predict Deep Inspiration Breath Hold Requirement for Locoregional Right-Sided Breast Radiation Therapy Patients. Biomed. Phys. Eng. Express (2024). at <http://iopscience.iop.org/article/10.1088/2057-1976/ad9b30>doi:10.1088/2057-1976/ad9b30
Lee, S. L., Bassetti, M. F. & Rusthoven, C. G. The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases. Seminars in Radiation Oncology 33, 181–192 (2023). doi:10.1016/j.semradonc.2022.11.008
Hwang, S. Y., Lee, S. L., Liu, H. & Lee, S. S. Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy? Liver Cancer 1–10 (2023). doi:10.1159/000534303
Hong, Y., Nixon, N., Cao, J. Q. & Lee, S. L. Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma. Frontiers in Oncology 13, (2023).
Lee, S. L. & Faruqi, S. Ten Percent Plexopathy Is Acceptable in This Case. International Journal of Radiation Oncology*Biology*Physics 114, 183–184 (2022). doi:10.1016/j.ijrobp.2022.07.020
Lee, S., Yadav, P., Kogel, A. J. van der, Bayouth, J. & Bassetti, M. F. In Silico Single-Fraction Stereotactic Ablative Radiation Therapy for the Treatment of Thoracic and Abdominal Oligometastatic Disease With Online Adaptive Magnetic Resonance Guidance. Advances in Radiation Oncology 6, (2021). doi:10.1016/j.adro.2021.100652
Lee, S. L., Yadav, P., Starekova, J., Christensen, L., Chandereng, T., Chappell, R., Reeder, S. B. & Bassetti, M. F. Diagnostic Performance of MRI for Esophageal Carcinoma: A Systematic Review and Meta-Analysis. Radiology 299, 583–594 (2021). doi:10.1148/radiol.2021202857
Lee, S. L., Mahler, P., Olson, S., Witt, J. S., Musunuru, H. B., Rajamanickam, V., Bassetti, M. F. & Yadav, P. Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer. Medical Dosimetry 46, 152–156 (2021). doi:10.1016/j.meddos.2020.10.002
Lee, S. L., Hall, W. A., Morris, Z. S., Christensen, L. & Bassetti, M. MRI-Guided Radiation Therapy. Advances in Oncology 1, 29–39 (2021). doi:10.1016/j.yao.2021.02.003
Lee, S. L., Bassetti, M., Meijer, G. J. & Mook, S. Review of MR-Guided Radiotherapy for Esophageal Cancer. Front. Oncol. 0, (2021). doi:10.3389/fonc.2021.628009
Cusumano, D., Boldrini, L., Yadav, P., Casà, C., Lee, S. L., Romano, A., Piras, A., Chiloiro, G., Placidi, L., Catucci, F., Votta, C., Mattiucci, G. C., Indovina, L., Gambacorta, M. A., Bassetti, M. & Valentini, V. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy. Diagnostics 11, 72 (2021). doi:10.3390/diagnostics11010072
Chow, R., Murdy, K., Vaska, M. & Lee, S. L. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis. Radiotherapy and Oncology 165, 37–43 (2021). doi:10.1016/j.radonc.2021.10.013
Chow, R., Lock, M., Lee, S. L., Lo, S. S. & Simone, C. B. Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”. Front. Oncol. 11, (2021). doi:10.3389/fonc.2021.700300